Profile picture

Doctor Elena Startseva

(Germany)
Follow
Logo ESC

Contributor content

Survodutide, a glucagon receptor/GLP-1 receptor (GCGR/GLP-1R) dual agonist, improves cardiometabolic parameters in adults with obesity: analysis of a placebo-controlled, randomised phase 2 trial
Presentation
Survodutide, a glucagon receptor/GLP-1 receptor (GCGR/GLP-1R) dual agonist, improves cardiometabolic parameters in adults with obesity: analysis of a placebo-controlled, randomised phase 2 trial
Read more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources